Kategorien
Aktien

Dr. Reddy’s Laboratories Limited

SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
NYSE New York Stock Exchange
Börse NYSE New York Stock Exchange
Symbol RDY
USD
  • Dr. Reddy's Laboratories Limited
    Börse NYSE New York Stock Exchange
    Symbol RDY
    USD
  • Dr. Reddy's Laboratories Limited
    Börse BSE
    Symbol DRRD.IS
    INR
  • INR
Symbol RDY
Währung USD
Börse NYSE New York Stock Exchange

Zahlte zuletzt am 08.07.2021 eine Dividende von 0,342  . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von

35 News & Informationen zur Dr. Reddy’s Laboratories Limited Aktie

  • Panacea Biotec To Manufacture Up To 25 Mn Doses Of Sputnik V Vaccine
    businessworld.in

    Panacea Biotec To Manufacture Up To 25 Mn Doses Of Sputnik V Vaccine

    Panacea Biotec shall produce the Sputnik V vaccine using the ready-to-fill drug substance manufactured by Generium in Russia, and then supply the entire quantity to Dr Reddy's for distribution in India, , Sputnik V vaccine, panacea biotec, manufacturing

  • Panacea Biotec to manufacture up to 25 mn doses of Sputnik V vaccine
    business-standard.com

    Panacea Biotec to manufacture up to 25 mn doses of Sputnik V vaccine

    Read more about Panacea Biotec to manufacture up to 25 mn doses of Sputnik V vaccine on Business Standard. Shares of Panacea Biotec ended at Rs 356.40 per scrip on BSE, up 2.77 per cent from its previous close.

  • Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q1 2021 Results - Earnings Call Transcript
    seekingalpha.com

    Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q1 2021 Results – Earnings Call Transcript

    Dr. Reddy's Laboratories Limited (NYSE:RDY) Q1 2021 Earnings Conference Call July 27, 2021 08:00 AM ET Company Participants Amit Agarwal – Head, Investor Relations & Director, Finance,…

  • Dr Reddy's Q1 results: Net profit falls 1% to Rs 571 cr, revenue up 11%
    businesstoday.in

    Dr Reddy's Q1 results: Net profit falls 1% to Rs 571 cr, revenue up 11%

    Dr Reddy's said it has launched Russia's Sputnik V vaccine in India across 80 cities, and over 2.5 lakh people have been vaccinated so far.

  • Dr Reddy's shares tumble over 10 per cent post earnings announcement
    thehindubusinessline.com

    Dr Reddy's shares tumble over 10 per cent post earnings announcement

    Dr Reddy's reported a 36 per cent decline in consolidated net profit for the quarter ended June 30, 2021

  • Dr Reddy's says investigating bribery allegations against it, in Ukraine and other CIS countries
    moneycontrol.com

  • Taking Stock: Indian indices fall on weak Asian cues; pharma worst hit
    moneycontrol.com

    Taking Stock: Indian indices fall on weak Asian cues; pharma worst hit

    On the BSE, healthcare and power indices lost 1.5-3 percent, while the metal index added 1.6 percent

  • Share market update: Most active stocks of the day in terms of traded value
    economictimes.indiatimes.com

    Share market update: Most active stocks of the day in terms of traded value

    The NSE Nifty index closed 78.0 points down at 15746.45

  • Dr Reddy's Labs Sheds 11% After Profit Falls 1.5% To Rs 570 Crore In June Quarter
    ndtv.com

    Dr Reddy's Labs Sheds 11% After Profit Falls 1.5% To Rs 570 Crore In June Quarter

    Dr Reddy's Share Price Today: On Tuesday, Dr Reddy's Labs opened on the BSE at Rs 5,421, inching to an intra day high of Rs 5,445, and an intra day low of Rs 4,786.26, so far

  • Dr Reddy Laboratories : . Reddy's Q1 FY22 Financial Results
    marketscreener.com

  • Dr Reddy's Laboratories share price falls 3% post June quarter result
    moneycontrol.com

    Dr Reddy's Laboratories share price falls 3% post June quarter result

    The share touched a 52-week high of Rs 5,613.65 and a 52-week low of Rs 3,963.85 on 07 July, 2021 and 27 July, 2020, respectively.

  • Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
    moneycontrol.com

    Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%

    Revenue from operations grew by 11.4 percent year-on-year to Rs 4,919.4 crore in Q1FY22

  • Share market update: Most active stocks on D-Street today in terms of volume
    economictimes.indiatimes.com

    Share market update: Most active stocks on D-Street today in terms of volume

    The NSE Nifty index was trading 50.65 points up at 15875.1

  • Buzzing Stocks: L&T, Axis Bank, Tata Motors and other stocks in news today
    moneycontrol.com

    Buzzing Stocks: L&T, Axis Bank, Tata Motors and other stocks in news today

    Stocks In the News: Check out the companies making the biggest headlines before the opening bell.

  • Trade setup for Tuesday: Top 15 things to know before Opening Bell
    moneycontrol.com

    Trade setup for Tuesday: Top 15 things to know before Opening Bell

    Nagaraj Shetti of HDFC Securities feels the short term trend of Nifty is choppy and similar movement could be expected for the next session.

  • Glenmark Life Sciences IPO opens on July 27: 10 things to know before the issue
    moneycontrol.com

    Glenmark Life Sciences IPO opens on July 27: 10 things to know before the issue

    Glenmark Life Sciences IPO: The company plans to raise Rs 1,497.85 crore at the lower end and Rs 1,513.6 crore at the higher end of the price band.

  • Sputnik V soft launched in over 50 cities in India: Dr Reddy's
    moneycontrol.com

  • Sensex, Nifty Follow Asian Peers Higher
    markets.businessinsider.com

    Sensex, Nifty Follow Asian Peers Higher

    (RTTNews) – Indian shares opened a tad higher Tuesday on the back of positive cues from other Asian markets after Chinese export data topped forec…

  • 2 Top Global Value Stocks to Buy Now
    fool.com

  • Hot Stocks | Can bet on Dr. Reddy's Labs, HDFC Bank and Hindalco for the short term
    moneycontrol.com

    Hot Stocks | Can bet on Dr. Reddy's Labs, HDFC Bank and Hindalco for the short term

    Near-term support for Nifty is placed near the 15,650 level and once the previous high of 15,915 is sustainably breached, it could rise towards the 16,000 mark and even higher, said xx of Bonanza Portfolio

  • 10 trading ideas for the next 3-4 weeks that could return 5-13%
    moneycontrol.com

    10 trading ideas for the next 3-4 weeks that could return 5-13%

    On the upside, stiff resistance is placed at 15900-16000. While on the downside, supports are placed at 15650-15450, suggest experts.

  • Stocks That Hit 52-Week Highs On Friday
    benzinga.com

    Stocks That Hit 52-Week Highs On Friday

    Before 10 a.m. ET Friday, 146 stocks hit new 52-week highs.
    Interesting Facts: The largest company by market cap to set a new 52-week high was …

  • Dr Reddy Laboratories : Annual Return
    marketscreener.com

    Dr Reddy Laboratories : Annual Return

    FORM NO. MGT-7

    [Pursuant to sub-Section of section 92 of the Companies Act, 2013 and sub-rule of rule 11of the Companies … | July 2, 2021

  • These 6 picks by technical experts can give 10-50% return over the next 3-6 months
    moneycontrol.com

    These 6 picks by technical experts can give 10-50% return over the next 3-6 months

    If the Nifty slides here on, 15,400 will be the decisive support and a breach will drag the index towards 15,000 that could again be a buying opportunity, say experts.

  • Stocks That Hit 52-Week Highs On Thursday
    benzinga.com

    Stocks That Hit 52-Week Highs On Thursday

    This morning 158 companies set new 52-week highs.
    Intriguing Points: NVIDIA (NASDAQ:NVDA) was the largest firm on a market cap basis to set a …

  • Sensex, Nifty End Lower For 4th Straight Day
    markets.businessinsider.com

    Sensex, Nifty End Lower For 4th Straight Day

    (RTTNews) – Indian shares ended weak on Thursday, weighed down by worries about the surge in the delta variant of the coronavirus cases across the…

  • Dr. Reddy's Laboratories Announces Filing Of Annual Report On Form 20-F
    thestreet.com

    Dr. Reddy's Laboratories Announces Filing Of Annual Report On Form 20-F

    Dr. Reddy's Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as

  • Stocks to watch: Vodafone Idea, SpiceJet, Union Bank, Dish TV, auto stocks
    business-standard.com

    Stocks to watch: Vodafone Idea, SpiceJet, Union Bank, Dish TV, auto stocks

    Read more about Stocks to watch: Vodafone Idea, SpiceJet, Union Bank, Dish TV, auto stocks on Business Standard. Shares of auto companies will be in focus as firms will release their sales figures for the month of June

  • B Medical Systems joins hands with Dr Reddy's for pan-India rollout of Sputnik V vaccines
    moneycontrol.com

    B Medical Systems joins hands with Dr Reddy's for pan-India rollout of Sputnik V vaccines

    Under the collaboration, the company will install several hundreds of vaccine freezers across the country for the national roll-out of Sputnik V vaccines, B Medical Systems said in a statement.

  • Dr Reddy's launches DRDO's COVID-19 drug 2-DG, priced at Rs 990
    businesstoday.in

    Dr Reddy's launches DRDO's COVID-19 drug 2-DG, priced at Rs 990

    In the initial weeks, the company will make the drug available in hospitals across metros and tier-1 cities, and subsequently the coverage will be expanded to the rest of India.

  • Sensex, Nifty End Modestly Lower
    markets.businessinsider.com

    Sensex, Nifty End Modestly Lower

    (RTTNews) – Indian shares gave up early gains to end modestly lower on Monday, with rising oil prices, mixed signals from Fed officials on the rat…

  • Dr Reddy's Labs share price gains over launch of COVID-19 treatment drug
    moneycontrol.com

    Dr Reddy's Labs share price gains over launch of COVID-19 treatment drug

    In the initial weeks, the Company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India, the company said in an exchange filing.

  • Why Amarin Fell Again Today
    fool.com

  • Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US
    businessworld.in

    Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US

    Shares of Dr Reddy's were trading 0.14 per cent lower at Rs 5,272.05 apiece on the BSE., , dr reddy, usfda, Ethyl Capsules, shares

  • Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US
    economictimes.indiatimes.com

    Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US

    Icosapent Ethyl Capsules, used to reduce triglyceride levels in adult patients have been launched by Dr. Reddy's Laboratories in the US market.

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Dir gefallen die Informationen zu Dr. Reddy’s Laboratories Limited?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Dr. Reddy’s Laboratories Limited?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Dr. Reddy’s Laboratories Limited?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Dr. Reddy’s Laboratories Limited?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero